RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Xiaohe Yang to Histone Deacetylase Inhibitors

Back to Details
This is a "connection" page, showing publications Xiaohe Yang has written about Histone Deacetylase Inhibitors.
Xiaohe Yang
Connection Strength
0.095
Histone Deacetylase Inhibitors
  1. Huang X, Wang S, Lee CK, Yang X, Liu B. HDAC inhibitor SNDX-275 enhances efficacy of trastuzumab in erbB2-overexpressing breast cancer cells and exhibits potential to overcome trastuzumab resistance. Cancer Lett. 2011 Aug 01; 307(1):72-79.
    View in: PubMed
    Score: 0.095
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support